单位：[1]Department of Nephrology, China-Japan Friendship Hospital, Beijing, China[2]Beijing University of Chinese Medicine, Beijing, China[3]Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China
第一作者单位：[1]Department of Nephrology, China-Japan Friendship Hospital, Beijing, China
通讯作者：
通讯机构：[1]Department of Nephrology, China-Japan Friendship Hospital, Beijing, China[*1]Department of Nephrology, China-Japan Friendship Hospital, No. 2 East Yinghuayuan Street, Chaoyang District, Beijing 100029, China.
推荐引用方式(GB/T 7714)：
Jiang Shimin,Fang Jinying,Yu Tianyu,et al.Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers for renal outcomes and mortality in diabetic kidney disease[J].EUROPEAN JOURNAL of INTERNAL MEDICINE.2021,85:127-129.doi:10.1016/j.ejim.2020.11.017.
APA：
Jiang, Shimin,Fang, Jinying,Yu, Tianyu&Li, Wenge.(2021).Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers for renal outcomes and mortality in diabetic kidney disease.EUROPEAN JOURNAL of INTERNAL MEDICINE,85,
MLA：
Jiang, Shimin,et al."Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers for renal outcomes and mortality in diabetic kidney disease".EUROPEAN JOURNAL of INTERNAL MEDICINE 85.(2021):127-129
